Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Crime
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • KYW News Radio

    Medical Report: Weight loss isn’t the only benefit of drugs like Ozempic, study says

    By Dr Brian Mc Donough,

    2024-07-22

    https://img.particlenews.com/image.php?url=0qJtrG_0uZ21B4g00

    PHILADELPHIA (KYW Newsradio) — Semaglutide is a medication sold under several brands, including Ozempic and Wegovy. The diabetes drug has gained a great deal of attention because it can be helpful in weight loss.

    Semaglutide is part of a group of drugs called glucagon-like peptide 1 (GLP-1) agonists. The drug was originally developed to help people with diabetes control their blood sugar.

    Over time, it became clear that the drug helped with weight loss, but a new study details an additional benefit. The New England Journal of Medicine has confirmed that semaglutide helps prevent long-term kidney damage and heart disease.

    However, these medications are quite complex, and a physician’s input is critical.

    Get more medical reports from Dr. Brian McDonough .

    ​​KYW Newsradio’s Medical Reports are sponsored by Independence Blue Cross.

    Expand All
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular
    Cooking With Maryann6 days ago

    Comments / 0